Astera Labs, Inc. (ALAB) Market Cap & Valuation Ratios
Astera Labs, Inc. (ALAB) has a market cap of $44.6B, a trailing P/E of 127.3 and a price-to-sales ratio of 37.1, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ALABAstera Labs, Inc.Follow ALAB — free
—
Price chart with a free account
- Market cap
- 44.6B
- P/E TTM
- 127.3
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Peers
semiconductors · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| ALAB | 45 | 127.3 | 36.1 | 151.9 | 0.6% | +98% | 23% | 17% |
| NXPI | 59 | 20.0 | 5.1 | 13.4 | 4.7% | +9% | 32% | 18% |
| MPWR | 56 | 69.6 | 16.7 | 54.6 | 1.0% | +29% | 29% | 29% |
| MCHP | 40 | 108.9 | 8.8 | 30.8 | 2.5% | +21% | 16% | 6% |
| STM | 39 | 244.6 | 2.9 | 18.4 | 0.1% | +10% | 1% | 0.5% |
| ON | 28 | 46.6 | 4.6 | 19.7 | 5.3% | -3% | 11% | 7% |
| CRDO | 28 | 52.2 | 16.9 | 49.6 | 1.6% | +165% | 32% | 36% |
| CBRS | 26 | — | — | — | — | — | -265% | — |
| GFS | 25 | 34.7 | 3.6 | 12.1 | 3.2% | +1% | 12% | 6% |
| TSEM | 19 | 66.2 | 11.0 | 31.4 | 1.6% | +15% | 16% | 8% |
| MTSI | 18 | 75.2 | 15.2 | 64.4 | 1.1% | +28% | 18% | 10% |
| Median of these 10 | 66.2 | 8.8 | 30.8 | 1.6% | +15% | 16% | 8% |
P/E 127.3 vs. a peer median of 66.2; EV/Sales 36.1 vs. 8.8.
Growth vs. price
each dot a company · hover or tap for valuesCBRS has no P/E (earnings not positive) and is left out · hover or tap a dot for values.
Astera Labs, Inc. — questions
- What is Astera Labs, Inc.'s market cap?
- $44.6B.
- What is Astera Labs, Inc.'s P/E ratio?
- 127.3 on trailing twelve-month earnings to 2026-06-30.
- What is Astera Labs, Inc.'s price-to-sales ratio?
- 37.1.
Every figure on this page comes from Astera Labs, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.